| Report ID | 260630 |
| Drug Identification Number | 02396688 |
| Brand name | TEVA-RIZATRIPTAN ODT |
| Common or Proper name | RIZATRIPTAN OD 10MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | RIZATRIPTAN |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL ORAL |
| Packaging size | PP 6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-06-18 |
| Estimated end date | 2026-01-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-06-19 | French | Compare |
| v1 | 2025-06-19 | English | Compare |